UPDATE : Monday, March 30, 2020
상단여백
Samsung BioLogics denies accounting irregularities by Lee Han-soo 2018-05-02 17:12
VC investment in biomedicine rises 200% y-o-y in Q1 by Nam Doo-hyun 2018-04-30 14:14
Chong Kun Dang wins US patent for anemia biosimilar by Lee Han-soo 2018-04-27 15:39
Hugel posts ₩45.8 billion in Q1 sales by Lee Han-soo 2018-04-26 12:51
Samsung BioLogics posts ₩131 billion in Q1 sales by Lee Han-soo 2018-04-25 17:47
라인
Pharma shares on the rise since early this year by Nam Doo-hyun 2018-04-25 13:56
NIBEC wins anti-cancer peptide patent in the US by Lee Han-soo 2018-04-23 15:15
Kolon unveils trial results for Invossa at cartilage repair conference by Lee Han-soo 2018-04-20 15:57
Blockbuster Remicade losing out to Korean biosimilars in US by So Jae-hyeon 2018-04-19 15:39
Hanmi gets FDA nod for nonalcoholic steatohepatitis treatment trials by Lee Han-soo 2018-04-19 15:29
라인
Biotech stocks could be overpriced: analysts by Nam Doo-hyun 2018-04-19 13:34
Pharmbio to market Shionogi’s dyspareunia treatment by Lee Han-soo 2018-04-18 14:10
ViroMed confirms VM202’s pain control in animal test by Nam Doo-hyun 2018-04-18 11:39
‘Genexine’s pipelines worth more than ₩3 trillion’ by Nam Doo-hyun 2018-04-16 15:48
Daewoong opens biotech research lab in Indonesia by So Jae-hyeon 2018-04-12 11:37
라인
Biotech CEOs roll up sleeves for global biz by So Jae-hyeon 2018-04-10 12:09
Samsung Bioepis settles patent disputes with AbbVie on Humira by Lee Han-soo 2018-04-06 15:21
CTC Bio gets sales nod for erectile dysfunction treatment in Vietnam by Lee Han-soo 2018-04-04 10:59
Steelmaker POSCO to challenge biotech sector by So Jae-hyeon 2018-04-03 11:58
Toolgen to develop hepatitis B treatment by Lee Han-soo 2018-03-30 17:28
여백
여백
여백
여백
Back to Top